Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux
Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux
复制标题
α-生育酚琥珀酸酯通过促进阿霉素流入和抑制阿霉素流出来增强阿霉素诱导的人胃癌细胞凋亡
DOI:
10.1016/j.canlet.2011.04.001
复制
发表时间:
2011-08-28
期刊:
影响因子:
9.7
通讯作者:
Wu, Kun
中科院分区:
文献类型:
--
作者:
Zhang, Xuguang;Peng, Xiangwen;Wu, Kun
Doxorubicin (DOXO), a chemotherapy drug, is widely used in clinic for treating a variety of cancers. However, the treatment eventfully fails due to drug resistance and toxicity. Therefore, a combination strategy is needed to increase efficacy and reduce toxicity of DOXO. alpha-tocopheryl succinate (alpha-TOS) exhibits anticancer actions in vitro and in vivo. Here, we reported that combination of DOXO + alpha-TOS cooperatively acted to induce apoptosis in SGC-7901 cells. alpha-TOS enhanced cellular level of DOXO via promotion of DOXO influx and suppression of DOXO efflux. DOXO induced MDR1 mRNA and protein expression and alpha-TOS inhibited this event, indicating that alpha-TOS suppressed DOXO efflux via inhibition of MDR1. Furthermore, combination of DOXO + alpha-TOS induced increased levels of Fas and Bax protein expression and cleavage of caspase-8 and caspase-9, suggesting that combination treatment induced Fas/caspase-8 and Bax mediated mitochondria dependent apoptosis. Taken together, our results demonstrated that alpha-TOS enhanced DOXO anticancer efficiency via promotion of DOXO influx and suppression of MDR-1 mediated DOXO efflux. (C) 2011 Elsevier Ireland Ltd. All rights reserved.